SCR-LIP-000601 · Claim · machine-readable JSON →

Ultrasound is used to measure subcutaneous thickness and stiffness for monitoring lipedema treatment, separately from diagnosis.

General proposition consolidated from 3 earlier single-paper claims; each study's own result is shown as its finding.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
low (GRADE)
Evidence
3 source(s)
Dates
2026-11-20 → 2026-11-20

Structured evidence, machine-compiled — not a verdict.

Evidence over time

2026Optimizing Liposuction in Lipedema Patients: A Novel Approach with Perioperative and Intraoperative Ultrasound. — Munoz J, Fons S, Fabbri M. (2026) · consistentClinical, ultrasound, elastography and bioimpedance changes after radial extracorporeal shock wave therapy in patients with lipedema: A prospective within-patient study. — Novo Rigueiro M, Bravo González M, Prado Moraña T, Pena Dubra A, Villarroel Comesaña S, Navarro Núñez P, Villamayor Blanco B, Novo Veleiro I. (2026) · consistentSerrapeptase After Liposuction for Lipedema: Limited Evidence for Antifibrotic Efficacy. — Bruno A, Saccoccio V. (2026) · consistent

Evidence (3)

Context (PECO)

Population24 women with lipedema undergoing lower extremity liposuction
Conditionlipedema
Exposureperioperative and intraoperative ultrasound to measure fat layer thickness
Comparatorpreoperative vs postoperative measurements
Outcomesuperficial subcutaneous fat (D1) thickness reduction
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Change log